IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

Detalles Bibliográficos
Autores principales: Kow, Chia Siang, Zaihan, Abdullah Faiz, Ramachandram, Dinesh Sangarran, Hasan, Syed Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Cytokine Stimulus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491934/
https://www.ncbi.nlm.nih.gov/pubmed/34628129
http://dx.doi.org/10.1016/j.cyto.2021.155730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491934/
https://www.ncbi.nlm.nih.gov/pubmed/34628129
http://dx.doi.org/10.1016/j.cyto.2021.155730

Ejemplares similares